Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Afshin Dowlati, MD

Afshin Dowlati, MD

  • Specialty: Hematology and Oncology
    View Expertise
  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English, French, Farsi

Office Locations

UH Seidman Cancer Center (0 mi.)

11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-3951

Biography: Afshin Dowlati, MD

Expertise

  • Experimental Therapeutics
  • Hematology/Oncology
  • Lung Cancer
  • Phase I Clinical Trials
  • Thoracic Cancer

Titles

  • Lucile and Robert H Gries Endowed Director, Center for Cancer Drug Development, University Hospitals
  • Director, Thoracic Oncology Program, UH Seidman Cancer Center
  • Director, Thoracic Oncology, UH Cleveland Medical Center
  • Director, Phase I Drug Development Program, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Rosalie and Morton A. Cohen Chair in Oncology, UH Seidman Cancer Center

Certifications & Memberships

  • Medical Oncology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1998 - 2000)

Fellowship | Hematology/Oncology
Hematology/Oncology - University Hospitals Of Cleveland (1996 - 1998)

Internship | Internal Medicine
Internal Medicine - Universite De Liege Faculte De Medecine (1992 - 1996)

Medical Education
Universite De Liege Faculte De Medecine (1992)

Featured Videos

Watch to find out more about this University Hospitals provider.

Patient Experience Reviews

4.9 out of 5
- based on 136 Ratings
(5)
5/8/2025

UH Seidman Cancer Center far exceeded my expectations with my treatment for *** cancer. Dr. Dowlati and his staff are experts in their profession and still show compassion whenever I see them. My cancer is not curable, but I feel a measure of comfort as they lead me on this journey. I have finished chemotherapy and am now in a type of remission thanks to the the knowledge and guidance of Dr. Dowlati and all of the staff at the center who took part in my care.

(5)
5/8/2025

Dr. Dowlati is one of the Kindest Drs. In years that I have meet. He explained things to me that I could understand & has a backup plan just in case. The PEOPLE ALL OF THEM work in tandem & also are Kind & Understanding. You get a sense of easy with having CANCER that is scary enough but everyone put me at easy. So Helpful since I'm so Scared. Its the complete turnkey of what to do & where to go! Thanks for being YOU ALL!

(5)
5/8/2025

Good

(5)
5/8/2025

I would actually be dead were it not for Dr Dowlati's care and expertise. He and the rest of my care team routinely exceed expectations.

(5)
3/2/2025

Provider is professional and straightforward

(5)
3/2/2025

Great service

(5)
3/2/2025

I felt very informed of future plans concerning my medical condition.

(5)
3/2/2025

This provider is an oncologist who is treating me for cancer. I trust him completely and couldn't ask for a better doctor. This appointment was to follow up on some scan and blood test results, and nothing changed with the treatment.

(5)
3/2/2025

Over all it was good

(5)
2/2/2025

Good

(5)
2/2/2025

Dr. Dowlati is an amazing doctor. He listens carefully and addresses my concerns. He is soft spoken, kind and seems to care deeply about my health care. I have recommended him to my friends and they are also very impressed with him. I'm so glad he's my oncologist!

(5)
1/3/2025

Totally trust him

(5)
12/3/2024

I was pretty frightened by my diagnosis of cancer. Dr explained everything to me (in the way of treatment and general outcome) and put me more at ease with what I will face in the future.

(5)
12/3/2024

Good

(5)
12/3/2024

I'm new to UH. I feel very good about the services I'm receiving from this organization!

(5)
12/3/2024

Provider was extremely great, I appreciated time spent with me

(5)
12/3/2024

I am very grateful for this provider

(5)
12/3/2024

He is always pleasant and willing to listen.

(5)
11/1/2024

Very pleased with UH healthcare team. Could not be better!

(5)
10/1/2024

A good experience. Dr. Dawlatti is always professional and caring

(5)
10/1/2024

I am seeing this provider for metastatic cancer treatment. He has been very good about explaining options to me and when he can, he gives me a choice of which direction to go, after explaining the benefits and risks. He's helping me a lot.

(5)
10/1/2024

The best

(5)
9/1/2024

Excellent care and follow up for my Cancer and lung breathing problems.

(5)
9/1/2024

Very good

(5)
9/1/2024

I appreciate Dr Dowlati's patience with me while I blabbered on during this appointment.

(5)
8/1/2024

All good

(5)
8/1/2024

Excellent provider, staff.

(5)
8/1/2024

Excellent doctor with immense expertise in his complicated field, coupled with a comforting style with the patient that has helped the patient both physically and mentally.

(5)
8/1/2024

Dr Dowlati & his staff are excellent. I owe him my life! Would highly recommend!!!

(5)
7/1/2024

I feel like initial plan of care was developed but never really talked to Dr about other options, long term prognosis

(5)
7/1/2024

I am very happy with my medical team at U.H.

(5)
7/1/2024

I'm thankful for Dr Dowlati because I'm still alive! Also, he has good ideas about what's going on with me health-wise outside of my cancer diagnosis. That helps me with achieving a better quality of life.

Related Blog Articles

clinical trials

Understanding Clinical Trials: What You Need To Know

Keeping up on the latest medical research can be a benefit, but the sheer amount of information – and the sometimes contradictory results – can be wearying.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Afshin Dowlati did not disclose any Outside Relationships with Industry.